Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/08/1997 | CA2194656A1 Partially lyophilized fructose-1,6-diphosphate (fdp) for injection into humans |
11/06/1997 | WO1997041443A2 Method for screening compounds |
11/06/1997 | WO1997041440A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes |
11/06/1997 | WO1997041263A1 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology |
11/06/1997 | WO1997041252A2 Dna, rna and a protein useful for detection of a mycobacterial infection |
11/06/1997 | WO1997041243A2 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene |
11/06/1997 | WO1997041236A1 Polynucleotide vaccine against canine distemper |
11/06/1997 | WO1997041230A2 Cc-type chemokines |
11/06/1997 | WO1997041225A2 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr] |
11/06/1997 | WO1997041222A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS |
11/06/1997 | WO1997041211A1 Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them |
11/06/1997 | WO1997041210A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna |
11/06/1997 | WO1997041206A2 Von willebrand factor multimerase |
11/06/1997 | WO1997041201A1 Anol esters as bleach activators for detergents and cleaners |
11/06/1997 | WO1997041156A1 Novel compounds |
11/06/1997 | WO1997041151A2 Choline binding proteins for anti-pneumococcal vaccines |
11/06/1997 | WO1997041148A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants |
11/06/1997 | WO1997041147A1 Novel compounds |
11/06/1997 | WO1997041146A1 Novel compounds |
11/06/1997 | WO1997041145A1 21-substituted progesterone derivatives as new antiprogestational agents |
11/06/1997 | WO1997041144A1 Novel steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs |
11/06/1997 | WO1997041141A1 Methods and compounds for curing diseases caused by mutations |
11/06/1997 | WO1997041129A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
11/06/1997 | WO1997041127A1 Halo-substituted protein kinase c inhibitors |
11/06/1997 | WO1997041125A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use |
11/06/1997 | WO1997041123A1 1-methylcarbapenem derivatives |
11/06/1997 | WO1997041121A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
11/06/1997 | WO1997041120A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
11/06/1997 | WO1997041119A1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
11/06/1997 | WO1997041115A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES |
11/06/1997 | WO1997041114A1 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle |
11/06/1997 | WO1997041108A1 Substituted piperazines and piperidines as central nervous system agents |
11/06/1997 | WO1997041104A1 Quinoline derivatives, processes for their preparation, and their use as medicaments |
11/06/1997 | WO1997041103A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs |
11/06/1997 | WO1997041102A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
11/06/1997 | WO1997041099A1 Azetidinone derivatives for the treatment of atherosclerosis |
11/06/1997 | WO1997041098A1 Azetidinone derivatives for the treatment of atherosclerosis |
11/06/1997 | WO1997041097A2 Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
11/06/1997 | WO1997041096A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
11/06/1997 | WO1997041090A1 Inorganic ion receptor-active compounds |
11/06/1997 | WO1997040861A1 Biological material free of viral and molecular pathogens and a process for the production thereof |
11/06/1997 | WO1997040857A1 Drug delivery using terminal complement components |
11/06/1997 | WO1997040855A1 Mammalian regulator of nonsense-mediated rna decay |
11/06/1997 | WO1997040854A2 Polypeptide conjugates for transporting substances across cell membranes |
11/06/1997 | WO1997040849A1 Method for treating or preventing ischemia-reperfusion injury |
11/06/1997 | WO1997040848A1 Use of prolactin as a tgf-beta antagonist |
11/06/1997 | WO1997040842A1 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy |
11/06/1997 | WO1997040841A1 Use of formes f hyaluronic acid (ha) for the treatment of cancer |
11/06/1997 | WO1997040840A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent |
11/06/1997 | WO1997040839A1 Dna vaccine formulations |
11/06/1997 | WO1997040838A1 New use |
11/06/1997 | WO1997040837A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
11/06/1997 | WO1997040836A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
11/06/1997 | WO1997040835A1 Treatment of carcinomas using squalamine in combination with other anti-cancer agents |
11/06/1997 | WO1997040834A1 Peripheral circulation improvers for ophthalmic tissues containing dihydropyridines |
11/06/1997 | WO1997040833A1 Hiv protease inhibitors useful for the treatment of aids |
11/06/1997 | WO1997040832A1 Use of dipeptidyl peptidase iv effectors for lowering the blood glucose level in mammals |
11/06/1997 | WO1997040831A1 Therapeutic treatment for vegf related occular diseases |
11/06/1997 | WO1997040830A1 Therapeutic treatment for vegf related diseases |
11/06/1997 | WO1997040829A1 Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy |
11/06/1997 | WO1997040828A1 Rapid-release s1452 tablets |
11/06/1997 | WO1997040827A1 Use of ethylene diamine disuccinate for preparing a medicament with antiviral properties |
11/06/1997 | WO1997040826A1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals |
11/06/1997 | WO1997040825A1 Hiv protease inhibitors useful for the treatment of aids |
11/06/1997 | WO1997040824A2 Propellant mixtures and aerosols for micronising medicaments with compressed gas |
11/06/1997 | WO1997040823A1 Oral pharmaceutical compositions containing sex hormones |
11/06/1997 | WO1997040819A1 Methods of dry powder inhalation |
11/06/1997 | WO1997040818A1 Biologically active composition |
11/06/1997 | WO1997040813A1 Composition, barrier film, and method for preventing contact dermatitis |
11/06/1997 | WO1997040792A1 Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers |
11/06/1997 | WO1997040776A1 Synchronising of animal oestrus and intra vaginal devices useful therein |
11/06/1997 | WO1997040680A1 Antioxidant compound |
11/06/1997 | WO1997036595A3 Medicament preparations containing tumour-inhibiting ruthenium (iii) complexes |
11/06/1997 | WO1997035969A3 Peptide ligands of the urokinase receptor |
11/06/1997 | WO1997034569A3 Pyronin antibacterials, process and intermediates |
11/06/1997 | WO1997033608A3 Antagonism of endothelin actions |
11/06/1997 | WO1997033566A3 Composition and dosage form comprising opioid antagonist |
11/06/1997 | DE19705277A1 Formulation for topical treatment of recurrent herpes diseases |
11/06/1997 | DE19616693A1 Enolester als Bleichaktivatoren für Wasch- und Reinigungsmittel Enol esters as bleach activators for washing and cleaning agents |
11/06/1997 | DE19616573A1 Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase Propellant mixtures and aerosols for the micronization of drugs using dense gases |
11/06/1997 | CA2668824A1 21-substituted progesterone derivatives as new antiprogestational agents |
11/06/1997 | CA2253608A1 Therapeutic treatment for vegf related diseases |
11/06/1997 | CA2253440A1 New use |
11/06/1997 | CA2253433A1 Mammalian regulator of nonsense-mediated rna decay |
11/06/1997 | CA2253346A1 Novel steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs |
11/06/1997 | CA2253313A1 Method for treating or preventing ischemia-reperfusion injury |
11/06/1997 | CA2253300A1 Biological material free of viral and molecular pathogens and a process for the production thereof |
11/06/1997 | CA2253288A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
11/06/1997 | CA2253282A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs |
11/06/1997 | CA2253263A1 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy |
11/06/1997 | CA2253252A1 Choline binding proteins for anti-pneumococcal vaccines |
11/06/1997 | CA2253229A1 Polynucleotide vaccine against canine distemper |
11/06/1997 | CA2252962A1 Peripheral circulation improvers for ophthalmic tissues containing dihydropyridines |
11/06/1997 | CA2252918A1 Hiv protease inhibitors useful for the treatment of aids |
11/06/1997 | CA2252915A1 Hiv protease inhibitors useful for the treatment of aids |
11/06/1997 | CA2252876A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
11/06/1997 | CA2252869A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
11/06/1997 | CA2252862A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent |
11/06/1997 | CA2252814A1 Methods of dry powder inhalation |
11/06/1997 | CA2252779A1 Use of ethylene diamine disuccinate for preparing a medicament with antiviral properties |